Publication List 2007

1984-94, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018

15
(304)
Iwata C, Kano MR, Komuro A, Oka M, Kiyono K, Johansson E, Morishita Y, Yashiro M, Hirakawa K, Kaminishi M, Miyazono K.
Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
Cancer Res. 2007 Nov 1;67(21):10181-9.
14
(303)
Hayashi M, Maeda S, Aburatani H, Kitamura K, Miyoshi H, Miyazono K, Imamura T.
Pitx2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins.
J Biol Chem. 2008 Jan 4;283(1):565-71.
13
(302)
Ehata S, Hanyu A, Hayashi M, Aburatani H, Kato Y, Fujime M, Saitoh M, Miyazawa K, Imamura T, Miyazono K.
Transforming growth factor-β promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1.
Cancer Res. 2007 Oct 15;67(20):9694-703.
12
(301)
Tokuda E, Fujita N, Oh-hara T, Sato S, Kurata A, Katayama R, Itoh T, Takenawa T, Miyazono K, Tsuruo T.
Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.
Cancer Res. 2007 Oct 15;67(20):9666-76.
11
(300)
Nakajima M, Kizawa H, Saitoh M, Kou I, Miyazono K, Ikegawa S.
Mechanisms for asporin function and regulation in articular cartilage.
J Biol Chem. 2007 Nov 2;282(44):32185-92.
10
(299)
Shirakihara T, Saitoh M, Miyazono K.
Differential regulation of epithelial and mesenchymal markers by δEF1 proteins in epithelial mesenchymal transition induced by TGF-β.
Mol Biol Cell. 2007 Sep;18(9):3533-44.
9
(298)
Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, Yuki K, Isogaya K, Saitoh M, Imamura T, Episkopou V, Miyazono K, Miyazawa K.
Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-β signaling.
J Biol Chem. 2007 Jul 13;282(28):20492-501.
8
(297)
Goto K, Kamiya Y, Imamura T, Miyazono K, Miyazawa K.
Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors.
J Biol Chem. 2007 Jul 13;282(28):20603-11.
7
(296)
Nakagome K, Dohi M, Okunishi K, Tanaka R, Kouro T, Kano MR, Miyazono K, Miyazaki J, Takatsu K, Yamamoto K.
IL-5-induced hypereosinophilia suppresses the antigen-induced immune response via a TGF-β-dependent mechanism.
J Immunol. 2007 Jul 1;179(1):284-94.
6
(295)
Shimanuki T, Hara T, Furuya T, Imamura T, Miyazono K.
Modulation of the functional binding sites for TGF-β on the type II receptor leads to suppression of TGF-β signaling.
Oncogene. 2007 May 17;26(23):3311-20.
5
(294)
Mishima K, Watabe T, Saito A, Yoshimatsu Y, Imaizumi N, Masui S, Hirashima M, Morisada T, Oike Y, Araie M, Niwa H, Kubo H, Suda T, Miyazono K.
Prox1 induces lymphatic endothelial differentiation via integrin α9 and other signaling cascades.
Mol Biol Cell. 2007 Apr;18(4):1421-9.
4
(293)
Kobayashi N, Goto K, Horiguchi K, Nagata M, Kawata M, Miyazawa K, Saitoh M, Miyazono K.
c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases.
Genes Cells. 2007 Mar;12(3):375-85.
3
(292)
Kano MR, Bae Y, Iwata C, Morishita Y, Yashiro M, Oka M, Fujii T, Komuro A, Kiyono K, Kaminishi M, Hirakawa K, Ouchi Y, Nishiyama N, Kataoka K, Miyazono K.
Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling.
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3460-5.
2
(291)
Ogawa K, Saito A, Matsui H, Suzuki H, Ohtsuka S, Shimosato D, Morishita Y, Watabe T, Niwa H, Miyazono K.
Activin-Nodal signaling is involved in propagation of mouse embryonic stem cells.
J Cell Sci. 2007 Jan 1;120(Pt 1):55-65.
1
(290)
Ehata S, Hanyu A, Fujime M, Katsuno Y, Fukunaga E, Goto K, Ishikawa Y, Nomura K, Yokoo H, Shimizu T, Ogata E, Miyazono K, Shimizu K, Imamura T.
Ki26894, a novel transforming growth factor-β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.
Cancer Sci. 2007 Jan;98(1):127-33.